Reaction
Postmenopausal Haemorrhage reporting signals
As of the last recalculation, Postmenopausal Haemorrhage appears in 2,545 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is PROGESTERONE (PRR 44.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Progesterone | 118 | 44.2 | 44.4 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 72 | 25.6 | 25.7 |
| Estradiol | 224 | 23.2 | 23.2 |
| Estradiol Gel 0.1% | 119 | 22.5 | 22.6 |
| Estradiol Transdermal | 119 | 22.5 | 22.6 |
| Raloxifene Hydrochloride | 26 | 14.7 | 14.7 |
| Standardized Senna Concentrate | 19 | 12.4 | 12.5 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 10 | 9.6 | 9.6 |
| Conjugated Estrogens | 63 | 9.0 | 9.0 |
| Estrogens, Conjugated | 63 | 8.9 | 8.9 |
| Medroxyprogesterone Acetate | 49 | 8.2 | 8.2 |
| Rivaroxaban | 193 | 8.1 | 8.1 |
| Cladribine | 9 | 7.7 | 7.7 |
| Liothyronine Sodium | 8 | 7.5 | 7.5 |
| Tirzepatide | 128 | 6.8 | 6.8 |
| Letrozole | 43 | 5.8 | 5.8 |
| Exemestane | 15 | 5.8 | 5.8 |
| Fexofenadine | 11 | 5.5 | 5.5 |
| Ropinirole | 10 | 5.3 | 5.3 |
| Copper | 26 | 5.0 | 5.0 |
| Triamcinolone Acetonide | 18 | 4.8 | 4.8 |
| Dronedarone | 5 | 4.0 | 4.0 |
| Liraglutide | 19 | 3.2 | 3.2 |
| Oral Semaglutide | 28 | 3.1 | 3.1 |
| Fremanezumab-Vfrm | 4 | 2.9 | 2.9 |
| Siponimod | 3 | 2.8 | 2.8 |
| Exenatide | 14 | 2.2 | 2.2 |
| Nirmatrelvir And Ritonavir | 14 | 2.1 | 2.1 |
| Orlistat | 5 | 1.6 | 1.6 |
| Levonorgestrel | 32 | 1.3 | 1.3 |